ArticleESMO open2025

Corrigendum to "Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study": [ESMO Open 9 (2024) 103702].

D Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.